Let’s talk cannabis.
There’s a lot of talk about CBD these days. The exact usage and medical benefits at this time are unclear. In the human field, there have been some studies looking into anti-seizure, anti-inflammatory, analgesic, anti-tumor, and anti-depression benefits of CBD with some promise. Here’s what we know:
• The 2018 Farm Bill defined hemp as any cannabis product containing less than 0.3% THC (this allows me to talk about it).
• It is anticipated the classification of cannabis will change from Schedule I (drugs that have no medical use like heroin & cocaine) to Schedule V (we can research it & make medications).
• We are talking about cannabidiol (CBD) which is found in cannabis. The FDA has already approved one human medication containing CBD for the treatment of epilepsy.
• We are NOT talking tetrahydrocannabinol (THC) which is the compound that has psychoactive properties (i.e. “gets you high”).
• When someone says hemp, think low THC & high CBD (hemp has been referred to as “anti-marijuana”).
• The body has an endocannabinoid system that CBD binds to. It is thought over 100 CBD compounds exist with many potential medical benefits.
• 2018 gave us 2 studies on CBD from Cornell & Colorado in dogs. There are many more to come with the changes in the law.
Why are we talking about this? Simple. People keep asking. Unfortunately, we haven’t even scratched the surface to unlock the benefits of these compounds. At this time, we do not recommend the use of phytocannabinoid therapies. A word of caution: A 2017 Penn study showed 70% of CBD products on the market are mislabeled. That 70% is only going to increase as the state & federal regulations are softened.